Resistance to TGFβ in SV40 large T-immortaIized rat intestinal epithelial cells is associated with down-regulation of TGFβ type I receptor

International Journal of Oncology

Volumn 9, Issue 2, 1996, Pages 365-374

  Mahida, Y R ^a   Djelloul, S ^b   Atfi, A ^b,c   Ciacci, C ^a   Debeaumont, M ^a   Chevalier, S ^c   Gespach, C ^b   Podolsky, D K ^a  

^a Center for Inflammatory Bowel Disease   (United States)

^b HÔPITAL SAINT ANTOINE   (France)

^c MONTREAL GENERAL HOSPITAL   (Canada)

Author keywords

Differentiation; Growth factors; Kinase; Oncogene; Proliferation

Indexed keywords

TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA RECEPTOR; VIRUS LARGE T ANTIGEN;

ANIMAL CELL; ARTICLE; CELL IMMORTALIZATION; CONTROLLED STUDY; INTESTINE EPITHELIUM CELL; MALIGNANT TRANSFORMATION; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR DOWN REGULATION; SIMIAN VIRUS 40; VIRUS ONCOGENE;

EID: 0030018431     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (56)

1. Leblond CP: The life history of cells in renewing systems. Am J Anat 160: 114-158, 1981.
2. Carroll KM, Wong TT, Drabik DL and Chang EB: Differentiation of rat small intestinal epithelial cells by extracellular matrix. Am J Physiol 254: 355-630, 1988.
3. Koyama S and Podolsky DK: Differential expression of transforming growth factors α and β in rat intestinal epithelial cells. J Clin Invest 83: 1768-1773, 1989.
4. Barnard JA, Beauchamp RD, Coffey RJ and Moses HL: Regulation of intestinal epithelial cell growth by transforming growth factor Type β. Proc Natl Acad Sci USA 86: 1578-1582, 1989.
5. Massague J: The transforming growth factor-β family. Annu Rev Cell Biol 6: 597-641, 1990.
6. Barnard JA, Lyons RM and Moses HL: The cell biology of transforming growth factor-β. Biochim Biophys Acta 1032: 79-87, 1990.
7. Lyons RM, Gentry LE, Purchio AP and Moses HL: Mechanism of activation of latent recombinant transforming growth factor β1 by plasmin. J Cell Biol 110: 1361-1367, 1990.
8. Wrana JL, Attisano L, Carcamo J, Zentella A, Doody J, Laiho A, Wang X-F and Massague J: TGFβ signals through a hetero-meric protein kinase receptor complex. Cell 71: 1003-1014, 1992.
9. Wrana JL, Attisano L, Wieser R, Ventura F and Massague J: Mechanism of activation of the TGF-β receptor. Nature 370: 341-347, 1994.
10. Heldin CJ: Dimerization of cell surface receptors in signal transduction. Cell 80: 213-223, 1995.
11. Franzen P, von Dijke P, Ichijo H, Yamahita H, Schulz P, Haldin CH and Miyazono K: Cloning of a TGFβ Type I receptor that forms a heteromeric complex with the TGFβ Type II receptor. Cell 75: 681-692, 1993.
12. Lin HY, Wang XF, Ng-Eaton B, Weinberg RA and Lodish HF: Expression cloning of the TGF-β Type II receptor, a functional transmembrane serine/threonine kinase. Cell 68: 795-805, 1992.
13. Wieser R, Wrana JL and Massague J: Gs domain mutations that constitutively activate TβR-I, the downstream signaling component in the TGF-β receptor complex. EMBO J 14: 2199-2208, 1995.
14. Atfi A, Lepage K, Allard P, Chapdelaine A and Chevalier S: Activation of a novel serine/threonine kinase signaling pathway by transforming growth factor β. Proc Natl Acad Sci USA 92: 12110-12114, 1995.
15. Quaroni A, Wands J, Trelstad RL and Isselbacher KJ: Epithelioid cell cultures from rat small intestine. Characterization by morphologic and immunologic criteria. J Cell Biol 80: 248-265, 1979.
16. Quaroni A and Isselbacher K: Cytotoxic effects and metabolism of benzo[a]pyrene and 7,12-dimethylbenzene[α]anthracene in duodenal and ileal epithelial cell cultures. J Natl Cancer Inst 67: 1353-1362, 1981.
17. Suh E and Traber P: An intestine-specific homeobox gene regulates proliferation and differentiation. Mol Cell Biol 16: 619-625, 1996.
18. Kurokawa M, Lynch K and Podolsky DK: Effects of growth factors on an intestinal epithelial cell line: transforming growth factor β inhibits proliferation and stimulates differentiation. Biochem Biophys Res Commun 142: 775-782, 1987.
19. Suemori S, Ciacci C and Podolsky DK: Regulation of transforming growth factor expression in rat intestinal epithelial cell lines. J Clin Invest 87: 2216-2221, 1991.
20. Furth ME, Aldrich TH and Cordon-Cardo C: Expression of ras proto-oncogene proteins in normal human tissues. Oncogene 1: 47-58, 1987.
21. Torelli G, Venturelli D, Colo A, Zanni C, Selleri L, Moretti L, Calabretta B and Torelli U: Expression of c-myb protooncogene and other cell cycle-related genes in normal and neoplastic human colonic mucosa. Cancer Res 47: 5266-5269, 1987.
22. Monnat M, Tardy S, Saraga P, Diggelmann H and Costa J: Prognostic implications of expression of the cellular gene myc, fos, Ha-ras and Ki-ras in colon carcinoma. Int J Cancer 40: 293-299, 1987.
23. Markowitz S, Wang J, Myeroff L, Parsons R, Sun L, Lutterbaugh J, Fan RS, Zborowska E, Kinzler KW, Vogelstein B, Brattain M and Willson JKV: Inactivation of the type II TGFβ receptor in colon cancer cells with microsatellite instability. Science 268: 1336-1338, 1996.
24. Emami S, Mir L, Gespach C and Rosselin G: Transfection of fetal rat intestinal epithelial cells by viral oncogenes: Establishment and characterization of the E1A-immortalized SLC-11 cell line. Proc Natl Acad Sci USA 86: 3194-3198, 1989.
25. Chastre E, Emami S, Rosselin G and Gespach C: Ontogenic development of vasoactive intestinal peptide receptors in rat intestinal cells and liver. Endocrinology 121: 2211-2221, 1987.
26. Del Castillo J: The use of hyperosmolar, intracellular-like solutions for the isolation of epithelial cells from guinea-pig small intestine. Biochim Biophys Acta 90: 201-208, 1987.
27. Parmjit SJ, Cepko CL, Mulligan RC and Sharp PA: Recombinant retroviruses encoding simian virus 40 large T antigen and polyomavirus large and middle T antigens. Mol Cell Biol 6: 1204-1217, 1986.
28. Emami S, Chastre E, Nizard S, DiGioia Y, Barbu V, Taillemitre JL, Ito S and Gespach C: Immortalization and neoplastic transformation of fetal rat intestinal epitnelial cells: morphological and cytogenetic analysis, (proto)oncogene expression and effect of γ-interferon on cell growth. Digestion 46: 74-91, 1990.
29. Danielpour D, Dart LL, Flanders KC, Roberts AB and Sporn MB: Immunodetection and quantitation of the two forms of transforming growth factor β (TGFβ1 and TGFβ2) secreted by cells in culture. J Cell Physiol 138: 79-86, 1989.
30. Chastre E, Di Gioia Y, Barbry P, Simon-Bouy B, Mornet E, Fanen P, Champigny G, Emami S and Gespach C: Functional insertion of the SV40 large T oncogene in cystic fibrosis intestinal epithelium. J Biol Chem 266: 21239-21246, 1991.
31. Chandler JA, Calnek D and Quaroni A: Identification and characterization of rat intestinal keratins. J Biol Chem 266: 11932-11938, 1991.
32. Filmus J, Church JG and Buick RN: Isolation of a cDNA corresponding to a developmentally regulated transcript in rat intestine. Mol Cell Biol 8: 4243-4249, 1988.
33. Chastre E, Empereur S, DiGioia Y, El Mahdana N, Marcel M, Vlerninckx K, Van Roy F, Bex V, Emami S, Spandidos DA, and Gespach C: Neoplastic progression of human and rat intestinal cell lines after transfer of the ras and polyoma middle T oncogenes. Gastroenterology 105: 1776-1789, 1993.
34. Suemori S, Ciacci C and Podolsky DK: Regulation of transformning growth factor expression in rat intestinal epithelial cell lines. J Clin Invest 87: 2216-2221, 1991.
35. Ciacci C, Lind SC and Podolsky DK: Transforming growth factor βregulation of migration in wounded rat intestinal epithelial monolayers. Gastroenterology 105: 93-101, 1993.
36. Ciacci C, Mahida YR, Dignass M, Koizumi M and Podolsky DK: Functional interleukin-2 receptors on intestinal epithelial cells. J Clin Invest 92: 527-532, 1993.
37. Paul E, Hochman J and Quaroni A: Conditionally immortalized intestinal epithelial cells: Novel approach for study of differentiated enterocytes. Am J Physiol 265: 266-278, 1993.
38. Moses HL, Tucker RF, Leof EB, Coffey RJ, Halper J and Shipley GD: Type-β transforming growth factor is a growth stimulator and a growth inhibitor. Cancer Cell 3: 65-71, 1985.
39. Assoian RK, Roberts AB, Waterfield LM, Anzano MA and Sporn MB: Transforming growth factors in non-neoplastic tissues and their role in controlling cell growth. Cancer Cell 3: 59-64, 1985.
40. Zhao J and Buick R: Relationship of levels and kinetics of H-ras expression to transformed phenotype and loss of TGF-β1-mediated growth regulation in intestinal cells. Exp Cell Res 204: 82-87, 1993.
41. Massague J: Receptors for the TGFβ family. Cell 69: 1067-1070, 1992.
42. Chen R-H, Ebner R and Derynck R: Inactivation of the Type II receptor reveals two receptor pathways for the diverse TGFβ activities. Science 260: 1335-1338, 1993.
43. Coffey RJ, Shipley GD and Moses HL: Production of transforming growth factors by human colon cancer lines. Cancer Res 46: 1164-1169, 1986.
44. Pietenpol JA, Holt JT, Stein RW and Moses HL: Transforming growth factor β1 suppression of c-myc gene transcription: Role in inhibition of keratinocyte proliferation. Proc Natl Acad Sci USA 87: 3758-3762, 1990.
45. Pietenpol JA, Stein RW, Moran E, Yaciuk P, Schlegel R, Lyons RM, Pittelkow MR, Munger K, Howley PM and Moses HL: TGFβ1 inhibition of c-myc transcription and growth in keratinocytes is abrogated by viral transforming proteins with pRB binding domains. Cell 61: 777-785, 1990.
46. Moses HL, Yang EY and Pietenpol JA: TGFβ Stimulation and inhibition of cell proliferation: new mechanistic insights. Cell 63: 245-247, 1990.
47. Berthon P, Mirossay L, Empereur S, Chastre E, De Cremoux P, Calvo F and Gespach C: VIP receptor activity and signal transduction in the cancerous progression of the mammary epithelium. Biomed Res 13: 169-180, 1992.
48. Ong G, Sikora K and Gullick WJ: Inactivation of the retinoblastoma gene does not lead to loss of TGFβ receptors or response to TGFβ in breast cancer cell lines. Oncogene 6: 761-773, 1991.
49. Chambard J-C and Pouyssegur J: TGFβ inhibits growth factor induced DNA synthesis in hamster fibroblasts without affecting the early mitogenic events. J Cell Physiol 135: 101-107, 1988.
50. 1 to S transition but not activation of human B lymphocytes. Exp Cell Res 171: 213-222, 1987.
51. Reiss M, Dibble CL and Narayanan R: Transcription activation of the c-myc proto-oncogene in murine keratinocytes enhances the response to epidermal growth factor. J Invest Dermatol 93: 136-141, 1989.
52. Telang NT, Osborne MP, Sweterlitsch LA and Narayanan R: Neoplastic transformation of mouse mammary epithelial cells by deregulated myc expression. Cell Regul 1: 863-872, 1990.
53. Stern DF, Roberts AB, Roche NS, Sporn MB and Weinberg RA: Differential responsiveness of myc- and ras-transfected cells to growth factors: selective stimulation of myc-transfected cells by epidermal growth factor. Mol Cell Biol 6: 870-877, 1986.
54. 1 cyclins and cyclin-dependent protein kinases. Proc Natl Acad Sci USA 90: 10315-10319, 1993.
55. Laiho M, Weis FMB and Massague J: Comcomitant loss of tranforming growth factor (TGF)-β receptor types I and II in TGF-β-resistant cell mutants implicates both receptor types in signal transduction. J Biol Chem 265: 18518-18524, 1990.
56. Chen R-H and Derynck R: Homodimeric interactions between type II transforming growth factor-β receptors. J Biol Chem 269: 22868-22874, 1994.